Dr. Deborah O. Dorman is a physician and expert in geriatric medicine who has worked extensively on the impact of polypharmacy among elderly populations. She has contributed to various studies focused on improving medication management and reducing the risks associated with multiple medications in older adults. Her research emphasizes creating patient-centric strategies to optimize medication regimens.
Dr. John B. McManus is a clinical pharmacologist and researcher with a focus on polypharmacy in aging populations. His work has provided valuable insights into the risks associated with multiple medications in older adults, particularly concerning drug interactions and adverse events. Dr. McManus advocates for regular medication reviews to reduce the incidence of polypharmacy-related issues.
Dr. William H. Shrank is an internationally recognized health policy expert and physician whose work on polypharmacy addresses both the clinical and financial impacts of multiple medications. As the Chief Medical Officer at a leading healthcare organization, he focuses on strategies to optimize prescribing practices and improve medication adherence while minimizing the costs associated with unnecessary medications.
Professor Jeffrey S. P. Bell is a pharmacist and researcher known for his work on the safe use of multiple medications in older adults. He has contributed extensively to the development of guidelines aimed at reducing polypharmacy-related harm. His research has led to better practices in medication review and management, particularly in long-term care settings.
Dr. Cheryl A. Hendricks is a geriatrician who has researched polypharmacy as it affects older adults with chronic conditions. She is involved in initiatives aimed at improving medication safety, focusing on reducing adverse drug reactions and ensuring that patients take only the medications they truly need. Dr. Hendricks is a leading voice in advocating for more integrated medication management in healthcare systems.
Dr. David M. Berman is a clinical pharmacologist whose research focuses on the prevention of polypharmacy and its related risks. He has published numerous studies on optimizing medication therapy for patients with multiple health conditions, emphasizing the importance of reviewing and reconciling prescriptions regularly to prevent unnecessary drug use.
Dr. Andrea L. Mitchell is a pharmacist specializing in polypharmacy management and medication safety in pediatric populations. Her work focuses on understanding how polypharmacy affects children with chronic illnesses and ensuring that medication regimens are safe and appropriate. She has developed several protocols for minimizing polypharmacy-related risks in pediatric care.
Dr. David R. Finkelstein is a leading researcher in the field of polypharmacy and patient safety. He has worked on projects that examine the role of pharmacists in reducing polypharmacy and its impact on patient health outcomes. Dr. Finkelstein is a strong advocate for integrating pharmacists into healthcare teams to ensure better medication management for patients with complex health needs.
Dr. Elizabeth T. Williams is a physician and researcher focused on reducing the harmful effects of polypharmacy in patients with multiple chronic conditions. Her research has contributed to the development of strategies for medication management in high-risk populations, including those with dementia and other age-related conditions.
Professor Mark D. K. Smith is a leading expert in pharmacology and public health. His work addresses the public health implications of polypharmacy, particularly in the context of aging populations. Professor Smith has written extensively on the need for policy reforms aimed at reducing the incidence of unnecessary medication use and improving medication management practices at the community level.